Global Nanomedicine Market – Drivers, Opportunities, Trends, and Forecasts: 2017–2023

Get in-depth COVID-19 impact and recovery analysis on the Global Nanomedicine Market

Flash Discount
15% Single User
20% Multi User
25% Corporate
30% Enterprise
  • Overview: Nanomedicine is an offshoot of nanotechnology, and refers to highly-specific medical intervention at the molecular scale for curing diseases or repairing damaged tissues. Nanomedicine uses nano-sized tools for the diagnosis, prevention and treatment of disease, and to gain increased understanding of the complex underlying pathophysiology of the disease. It involves three nanotechnology areas of diagnosis, imaging agents, and drug delivery with nanoparticles in the 1–1,000 nm range, biochips, and polymer therapeutics.

    The majority of nanomedicines used now allow oral drug delivery and its demand is increasing significantly. Although these nanovectors are designed to translocate across the gastrointestinal tract, lung, and blood–brain barrier, the amount of drug transferred to the organ is lower than 1%; therefore improvements are challenging. Nanomedicines are designed to maximize the benefit/risk ratio, and their toxicity must be evaluated not only by sufficiently long term in vitro and in vivo studies, but also pass multiple clinical studies.

    The major drivers of the nanomedicine market include its application in various therapeutic areas, increasing R&D studies about nanorobots in this segment, and significant investments in clinical trials by the government as well as private sector. The Oncology segment is the major therapeutic area for nanomedicine application, which comprised more than 35% of the total market share in 2016. A major focus in this segment is expected to drive the growth of the nanomedicine market in the future.

    Market Analysis: The “Global Nanomedicine Market” is estimated to witness a CAGR of 17.1% during the forecast period 2017–2023. The nanomedicine market is analyzed based on two segments – therapeutic applications and regions.

    Regional Analysis: The regions covered in the report are the Americas, Europe, Asia Pacific, and Rest of the World (ROW). The Americas is set to be the leading region for the nanomedicine market growth followed by Europe. The Asia Pacific and ROW are set to be the emerging regions. Japan is set to be the most attractive destination and in Africa, the popularity and the usage of various nano-drugs are expected to increase in the coming years. The major countries covered in this report are the US, Germany, Japan, and Others.

    Therapeutic Application Analysis: Nanomedicines are used as fluorescent markers for diagnostic and screening purposes. Moreover, nanomedicines are introducing new therapeutic opportunities for a large number of agents that cannot be used effectively as conventional oral formulations due to poor bioavailability. The therapeutic areas for nanomedicine application are Oncology, Cardiovascular, Neurology, Anti-inflammatory, Anti-infectives, and various other areas. Globally, the industry players are focusing significantly on R&D to gain approval for various clinical trials for future nano-drugs to be commercially available in the market. The FDA should be relatively prepared for some of the earliest and most basic applications of nanomedicine in areas such as gene therapy and tissue engineering. The more advanced applications of nanomedicine will pose unique challenges in terms of classification and maintenance of scientific expertise.

    Key Players: Merck & Co. Inc., Hoffmann-La Roche Ltd., Gilead Sciences Inc., Novartis AG, Amgen Inc., Pfizer Inc., Eli Lilly and Company, Sanofi, Nanobiotix SA, UCB SA and other predominate & niche players.

    Competitive Analysis: At present, the nanomedicine market is at a nascent stage – but, a lot of new players are entering the market as it holds huge business opportunities. Especially, big players along with the collaboration with other SMBs for clinical trials of nanoparticles and compounds are coming with new commercial targeted drugs in the market and they are expecting a double-digit growth in the upcoming years. Significant investments in R&D in this market are expected to increase and collaborations, merger & acquisition activities are expected to continue.

    Benefits: The report provides complete details about the usage and adoption rate of nanomedicines in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, government initiatives towards the nanomedicine adoption in the upcoming years along with the details of commercial drugs available in the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.


  • With tables and figures helping analyze worldwide Global Nanomedicine market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    1 Industry Outlook 10

    1.1 Industry Overview 10

    1.2 Industry Trends 11

    1.3 PEST Analysis 12

    2 Report Outline 12

    2.1 Report Scope 12

    2.2 Report Summary 13

    2.3 Research Methodology 14

    2.4 Report Assumptions 14

    3 Market Snapshot 16

    3.1 Total Addressable Market (TAM) 16

    3.2 Segmented Addressable Market (SAM) 16

    3.3 Related Markets 17

    3.3.1 mHealth Market 17
    3.3.2 Healthcare Analytics Market 18

    4 Market Outlook 18

    4.1 Overview 18

    4.2 Regulatory Bodies and Standards 19

    4.3 Government Spending and Initiatives 19

    4.4 Porter 5 (Five) Forces 21

    5 Market Characteristics 22

    5.1 Evolution 22

    5.2 Ecosystem 25

    5.2.1 Regulatory Process 25
    5.2.2 Clinical Trials 25
    5.2.3 Pricing and Reimbursement 26

    5.3 Market Segmentation 28

    5.4 Market Dynamics 28

    5.4.1 Drivers 29 Emergence of nanorobotics 29 Applications and advantages of nanomedicine in various healthcare segments 29 Reasonable investments in R&D 30 Increased support from governments 30
    5.4.2 Restraints 31 Long approval process and stringent regulations 31 Problems regarding nanoscale manufacturing 31 Risks related to nanomedicines 31 Undefined regulatory standards 31
    5.4.3 Opportunities 32 Aging population with chronic care needs 32 Population and income growth in emerging countries 32
    5.4.4 DRO – Impact Analysis 33

    6 Trends, Roadmap and Projects 34

    6.1 Market Trends and Impact 34

    6.2 Technology Roadmap 35

    7 Types: Market Size and Analysis 36

    7.1 Overview 36

    7.2 Global Nanomedicine Market in Oncology Segment 37

    7.3 Global Nanomedicine Market in Cardiovascular Segment 38

    7.4 Global Nanomedicine Market in Neurology Segment 39

    7.5 Global Nanomedicine Market in Anti-inflammatory Segment 39

    7.6 Global Nanomedicine Market in Anti-infective Segment 40

    7.7 Global Nanomedicine Market in Other Therapeutic Areas 41

    8 Trending Nanomedicines 42

    8.1 Overview 42

    8.2 Abraxane 43

    8.3 Alimta 43

    8.4 Eligard 44

    8.5 Copaxone 44

    8.6 Rapamune 44

    8.7 Neulasta 45
    8.8 Cimzia 45
    8.9 AmBisome 46
    8.10 Mircera 46
    8.11 Pegasys 46
    8.12 Emend 47
    8.13 Renagel 47
    8.14 Ritalin 47

    9 Regions: Market Size and Analysis 48

    9.1 Overview 48

    9.1.1 Global Nanomedicine Market by Geographical Segmentation 49

    9.2 Key Leading Countries 49

    9.2.1 US 49
    9.2.2 Germany 50
    9.2.3 Japan 50

    10 Vendor Scenario 50

    11 Vendor Profiles 53

    11.1 Merck & Co. Inc. 53

    11.1.1 Overview 53
    11.1.2 Business Unit 55
    11.1.3 Geographic Revenue 57
    11.1.4 Recent Developments 58
    11.1.5 SWOT Analysis 58
    11.1.6 Business Strategies 60

    11.2 Hoffmann-La Roche Ltd. 60

    11.2.1 Overview 60
    11.2.2 Business Unit 61
    11.2.3 Geographic Revenue 63
    11.2.4 Recent Developments 63
    11.2.5 SWOT Analysis 65
    11.2.6 Business Strategies 66

    11.3 Gilead Sciences 66

    11.3.1 Overview 66
    11.3.2 Business Unit 68
    11.3.3 Geographic Revenue 70
    11.3.4 Recent Developments 70
    11.3.5 SWOT Analysis 71
    11.3.6 Business strategies 71

    11.4 Novartis AG 71

    11.4.1 Overview 71
    11.4.2 Business Unit 72
    11.4.3 Geographic Revenue 74
    11.4.4 Recent Developments 74
    11.4.5 SWOT Analysis 76
    11.4.6 Business Strategies 76

    11.5 Amgen Inc. 77

    11.5.1 Overview 77
    11.5.2 Business Unit 78
    11.5.3 Geographic Revenue 79
    11.5.4 Recent Developments 79
    11.5.5 SWOT Analysis 80
    11.5.6 Business Strategies 81

    12 Global Generalist 82

    12.1 Pfizer Inc. 82

    12.1.1 Overview 82
    12.1.2 Recent Developments 82
    12.1.3 Pfizer in 2015 83

    12.2 Eli Lilly and Company 84

    12.2.1 Overview 84
    12.2.2 Recent Developments 85
    12.2.3 Eli Lilly and Company in 2015 85

    12.3 Sanofi 86

    12.3.1 Overview 86
    12.3.2 Recent Developments 86
    12.3.3 Sanofi in 2015 87

    13 Companies to Watch for 87

    13.1 Nanobiotix SA 87

    13.1.1 Overview 87
    13.1.2 Offering 88
    13.1.3 Recent Developments 88

    13.2 UCB SA 89

    13.2.1 Overview 89
    13.2.2 Offering 89
    13.2.3 Recent Developments 90

    14 Market Landscape 91

    14.1 Market Landscape 91

    14.1.1 Mergers & Acquisitions (M&A) 91
    Annexure 93
     Abbreviations 93


  • The Global Nanomedicine Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
    • Merck & Co.Inc
    • Hoffmann-La Roche Ltd
    • Gilead Sciences
    • Novartis AG
    • Amgen Inc
    • Pfizer Inc
    • Eli Lilly and Company
    • Sanofi
    • Nanobiotix SA
    • UCB SA.
    By Regions:
      By Type:
        By Application:
        Licensing options

        Need assistance ?

        Research objectives

        Where will all these developments take the industry in the long

        To study and analyze the global Market consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.

        What are the future opportunities in the market?

        To understand the structure of Market by identifying its various subsegments.

        What are the major driving forces expected to impact the development of the market market across different regions?

        To analyze the market with respect to individual growth trends, future prospects, and their contribution to the total market.

        Which industry trends are likely to shape the future of the industry during the forecast period 2020-2025?

        To project the consumption of market submarkets, with respect to key regions.

        Who are the major driving forces expected to decide the fate of the industry worldwide.

        To strategically profile the key players and comprehensively analyze their growth strategies.

        What are the key barriers and threats believed to hinder the development of the industry?

        To analyze competitive developments such as expansions,agreements, new product launches, and acquisitions in the market.

        Who are the prominent market players making a mark in the market with their winning strategies?

        To share detailed information about the key factors influencing the growth of the market

        What will be the growth rate and the market size of the industry for the forecast period 2020-2025?

        Focuses on the key global market Vendors, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

        Our Clients